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The Prognostic Value of Cardiac CT After
Coronary Artery Bypass Surgery
As Easy as 1, 2, 3?*
Patrick T. O’Gara, MD,† Ron Blankstein, MD†‡
Boston, Massachusettsi
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mOver the past decade, coronary computed tomo-
graphic angiography (CTA) has emerged as a useful
noninvasive test to evaluate selected low-to-
intermediate risk patients with suspected coronary
artery disease (CAD). In this population, the ab-
sence of coronary stenoses on CTA can exclude the
presence of obstructive disease with a negative
predictive value that exceeds 90%. Coronary CTA
See page 496
can also detect nonobstructive plaque, which sig-
nifies the presence of subclinical disease and often
leads to intensification of medical therapy for
primary prevention (1). However, in higher risk
populations, the potential advantages of CTA
can be offset by the fact that the functional
significance of a moderate to severe stenosis (i.e.,
50% ) is often unknown (2). A physiological
assessment of lesion severity is often required,
especially in patients for whom coronary revascu-
larization is being considered.
The evaluation and management of symptomatic
patients after coronary artery bypass graft (CABG)
surgery represents a challenging area for clinicians.
Notably, these patients—who are rarely included in
clinical trials—have increased morbidity and mor-
tality rates when undergoing repeat revasculariza-
tion, whether percutaneous or surgical. The cause of
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the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
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pital and Harvard Medical School, Boston, Massachusetts. The authors
have reported that they have no relationships to disclose.schemic symptoms in this population may be due
o disease involving either or both of the native
oronary arteries and bypass conduits. At 10 years
fter CABG surgery, approximately 50% of vein
rafts and 10% of internal mammary arterial grafts
re occluded (3); long-term patency rates with
adial grafts are less well established. Consequently,
hen assessing the prognosis of patients after
ABG surgery, it is essential to integrate data on
he integrity of both the native coronary and bypass
raft circulations (4). Other important variables
nclude left ventricular systolic function, arrhythmic
ubstrate, mitral regurgitation, diabetes, and the
cope and intensity of medical therapy.
The noninvasive evaluation of symptomatic pa-
ients after CABG surgery has traditionally relied
n the assessment of myocardial perfusion and
unction. More recently, it has been shown that
oronary CTA can accurately identify the presence
f stenosis in both venous and arterial bypass grafts
5). However, the diagnostic accuracy of CTA to
valuate the native coronary arteries in patients with
revious CABG is limited by extensive vessel wall
alcification frequently observed in those with
hronic CAD. In addition, the evaluation of
ypass grafts with CTA is vulnerable to artifacts
rom metal clips. Such artifacts can be particu-
arly problematic if they occur at the site of the
istal graft anastomosis, a location that demands
areful evaluation.
In this issue of the iJACC, Chow et al. (6) report
he first study evaluating the prognostic value of
oronary CTA in patients with previous CABG
urgery. They followed 250 patients who had pre-
ious CABG surgery over a mean of 20.8  10.0
onths using a composite hard endpoint of cardiaceath and nonfatal myocardial infarction.
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504To capture anatomic information regarding both
native coronary arteries and bypass grafts, patients
were categorized according to the number (i.e., 0, 1,
2, or 3) of unprotected coronary territories (UCTs).
An unprotected territory was defined by: 1) signif-
icant obstructive CAD in a native, ungrafted
vessel; 2) significant obstructive CAD in a native
vessel distal to the site of graft anastomosis; and
3) significant obstructive disease involving both the
native artery and its bypass graft. Using this index,
the observed annual event rate (cardiac death, non-
fatal myocardial infarction) was 2.4%, 5.8%, 11.1%,
and 21.7% for patients with 0, 1, 2, or 3 UCTs,
respectively. Thus, the number of UCTs enabled
the identification of patient subgroups with pro-
gressively worse outcomes. Furthermore, the au-
thors suggest that number of UCTs may provide
prognostic information incremental to that which is
available from routine clinical variables.
This investigation advances our knowledge re-
garding the application of coronary CTA to CABG
patients and supports the biologically plausible hy-
pothesis that the prognosis of these patients de-
pends on the integrity of both the native coronary
arteries and bypass grafts. However, the findings of
this study must be interpreted with caution. First, to
identify the incremental value of any imaging study,
it is important to consider all the nonimaging risk
markers that are typically available to clinicians. In
this study, the authors chose to incorporate clinical
variables and scoring systems targeted traditionally
to patients considered at risk of CAD. Their
applicability to a population of patients with estab-
lished CAD is limited. It is not surprising that the
clinical model used in this study had a poor ability
to discriminate between patients with and without
events (c-statistic: 0.61). Although the addition of
the UCT index improved the c-statistic, it may not
have done so to this extent if the clinical model had
been more robust, with inclusion of other variables
such as left ventricular ejection fraction, time since
revascularization, type of conduits used, intensity of
medical therapy, and smoking status.
A second limitation of the study is that, by
definition, the categorization of the number of
UCTs also relies heavily on the ability to evaluate
small-caliber distal vessels. However, as discussed
previously, the majority of patients with a previous
CABG have significant degrees of native vessel
calcification that render many segments nonassess-
able. In the study by Chow et al. (6), readers were
forced to provide “their best educated guess” for
nonassessable segments (patients were only ex- bcluded if there were 5 nonassessable segments, a
criterion that only applied to 10 patients). Although
specific data regarding the number of nonassessable
segments are not provided, it is almost certain that
there were far more nonassessable segments involv-
ing native coronary arteries than bypass grafts.
A useful statistic used in this study is the net
reclassification index (NRI). The NRI is a propor-
tion that represents the net number of individuals in
hom events develop who are appropriately up-
lassified to a higher risk category plus the number
f patients in whom events do not develop who are
ppropriately down-classified to a lower risk cate-
ory (7). The authors report an NRI of 27%,
uggesting that that the proportion of patients who
ere appropriately up-classified or down-classified
inus the proportion of patients who were inap-
ropriately up-classified or down-classified was ap-
roximately one-fourth. Although this is a sizable
roportion, the NRI provided in this paper is
ifficult to interpret because the NRI depends on
he categories of risk chosen. These categories must
e clinically meaningful (i.e., patients in different
ategories will be treated differently) because a
enefit could only occur if reclassification would
ead to differences in patient management. As
oted, the categories of risk chosen in this study
10%, 10% to 20%, 20%) are less applicable to
he management of patients with established CAD
fter CABG surgery, particularly because most are,
y definition, high risk.
If we calculate the components of the NRI in this
tudy, we observe that among the 23 patients who
xperienced events, the NRI was approximately
4% (4 were up-classified, whereas 5 were inap-
ropriately down-classified). Among the 227 pa-
ients who experienced no events, the NRI was
pproximately 32% (80 were down-classified,
hereas 7 were inappropriately up-classified). This
uggests that the benefit captured by the NRI
tatistic was entirely driven by the ability of the
CT index to appropriately down-classify patients
n whom events did not occur. Although 94% (80 of
he 85) of patients who were down-classified experi-
nced no events, only 4 of 11 patients who were
p-classified experienced events (it is unknown
hether any of them were revascularized). These
ndings are consistent with the known high negative
redictive value of coronary CTA and suggest that its
ositive predictive value for identifying patients who
xperienced adverse events is more limited.
How can the information provided by this study
e used to improve patient outcomes? Intuitively,
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505we would want to treat higher risk patients more
aggressively. However, most such patients should
already be on evidence-based secondary prevention
therapy with aspirin, statins, beta-blockers, and
angiotensin-converting enzyme inhibitors when in-
dicated. The next most relevant question is whether
patients with increased UCT indices would benefit
from repeat coronary revascularization. Given that
both symptoms and the physiological significance
of a lesion are important predictors of the benefit
of coronary revascularization, future studies
should examine the incremental value of combin-
ing the anatomic data obtained with coronary
CTA with functional data derived from myocar-
dial perfusion imaging.
Although the number of UCTs is a useful
marker, which integrates data on clinically relevant
obstructive disease, it may not maximize the poten-
tial information that can be obtained with cardiac
computed tomography. Future studies should in-
corporate data regarding: 1) the presence and extent
of nonobstructive plaque in both native vessel and
bypass grafts; 2) type of grafts used; 3) the presence
and extent of previous myocardial infarction; and
4) global and regional left ventricular function.
Such studies will require a large, ideally multi-3. Eagle KA, Guyton RA, Davidoff R, et al.
ACC/AHA 2004 guideline update for
4
5
6. Chow BJW, Osman
Prognostic value of CIn conclusion, the study by Chow et al. (6)
provides important evidence that the anatomic in-
formation provided by coronary CTA is prognosti-
cally important and can identify patients with a
high rate of cardiovascular death or myocardial
infarction. So is an initial evaluation of coronary
and bypass graft anatomy as easy as 1, 2, 3, a good
starting point from which to separate low- from
high-risk patients? The answer likely depends on
the patient population studied. In the study by
Chow et al. (6), 51% of patients had no abnormal
territories (UCTs  0), whereas 20% had 2
UCTs. Will this distribution of disease be observed
in other centers? Can we identify better pre-
imaging risk models that can help identify which
patients should first be evaluated with coronary
CTA versus those who may benefit from perfusion
and functional imaging? Will patient management,
and ultimately outcomes, be influenced by our
imaging studies? If only it were that easy . . .
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